Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases

Background . Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited. Clinical case description . Authors have presented three cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatricheskai͡a︡ farmakologii͡a︡ : nauchno-prakticheskiĭ zhurnal Soi͡u︡za pediatrov Rossii 2025-01, Vol.21 (6), p.496-502
Hauptverfasser: Ibisheva, Aset Kh, Shakhgireeva, Madina R., Dzhabrailova, Linda V.-M., Khildikharoeva, Asya B., Uspanova, Linda S., Getaeva, Kamila A.-R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background . Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited. Clinical case description . Authors have presented three clinical cases of CSU onset after the new coronavirus infection. Clinical features of disease and targeted therapy efficacy were evaluated. Conclusion . T he course of CSU, potentially triggered by SARS-CoV-2, has its own features, and requires larger research with the study of clinical and laboratory aspects, as well as the immunological mechanisms underlying the disease, with revealing biomarkers indicating disease severity, course, and prognosis.
ISSN:1727-5776
2500-3089
DOI:10.15690/pf.v21i5.2798